Log In
Print this Print this

TB Patch

  Manage Alerts
Collapse Summary General Information
Company Sequella Inc.
DescriptionPatch delivering recombinant protein MPT64
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase III
Standard IndicationInfectious, Diagnostic
Indication DetailsDetect active tuberculosis (TB) infection
Regulatory Designation
PartnerJapan BCG Laboratory Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today